← All candidates
35 insider filings on record.
35 filings on record.
SVRASavara Inc
NasdaqGS · Healthcare · $1.24B
$5.34
-1.50% · Sep 15
35 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 2 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.24B
Float
130.1M
63% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Hawkins Richard J
Bought $98.6K on Jun 20 — 48,225 sh @ $2.04, held direct, 42% of their stake.
1 of 1 position beat the S&P
Director
McCracken Joseph S
Bought $20.8K on May 29 — 10,000 sh @ $2.08, held direct, 3.8% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
30 more transactions on Pro →Context
Wall St
$10.94 avg target
+104.8% vs today · 8 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 3 quarters beat
Q2 '26−$0.16 act−$0.01
Q4 '25−$0.13 act−$0.01
Q3 '25−$0.14 act−$0.01
Coverage
Here's Why You Should Add Savara Stock to Your Portfolio NowZacks · 07-22What Savara Investors Should Know About This 580,187-Option Exercise and FDA TimelineMotley Fool · 06-27Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term ReturnsSimply Wall St. · 06-08Savara Inc. (SVRA) Reports Q1 Financial ResultsInsider Monkey · 05-22
The file stays open
35 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice